MEC_Impact Report_2026 - Flipbook - Page 14
Impact Report 2026
Strategic objective 3:
Support patient care
By supporting innovation, clinical excellence and patient-centred approaches,
Moorfields Eye Charity is helping to improve care for people affected by sight
loss. From pioneering new treatments to harnessing artificial intelligence for
earlier and more accurate diagnosis, these advances are transforming lives.
Restoring vision: how a patient helped
shape a world-first hypotony treatment
When Nicki began losing her
At the time, there were no
sight due to hypotony, a rare
established treatments that
oil is often quite good, but
condition caused by abnormally
could reliably stabilise and
if you have the potential of
low pressure within the eye,
reverse hypotony. As Mr
having good vision, oil is not
she was determined not to
Harry Petrushkin, consultant
necessarily the best option.
accept the limited treatment
ophthalmologist and
options available.
clinical director for digital
Rather than accept the
engagement at Moorfields Eye
status quo, Nicki continued
Hospital, explained:
to ask questions and explore
Having already experienced
significant vision loss in one
eye, Nicki was intent on
alternatives.
One of the biggest gaps I
avoiding the same outcome
felt existed was that nobody
in the other. The prospect of
was really working on
losing more vision brought with
hypotony.
it the worry of being unable to
I kept saying, ‘There has to
be something else we can do.’
Supported by an innovation
share precious moments with
Injecting silicone oil inside the
grant from Moorfields Eye
her son. Nicki said:
eye had been the standard of
Charity, Mr Petrushkin and
care for many years. While it
colleagues developed and
is a stable substance, it can
trialled a new treatment using
a fear of missing my son’s
cause complications over time
hydroxypropyl methylcellulose
childhood.
and is not easy to see through.
(HPMC) gel to restore the eye’s
Mr Petrushkin said:
volume and pressure.
The biggest impact was
14
If you have poor vision,